HAL vs TRAW · P/E 9.3, $19.05B cap vs rev $226.0K
Halliburton Company (HAL) versus Traws Pharma Inc (TRAW) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported TRAW revenue for 2024-12-31 was $226.0K. Net income was -$166.5M. Revenue was up 0.0% from 2023-12-31 to 2024-12-31. TRAW currently screens at market cap $12.1M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. TRAW currently screens at market cap $12.1M.
Not investment advice. Open the HAL and TRAW stock pages for the full models.
Not investment advice.